Platelet Function Decreases with Increasing Severity of Liver Cirrhosis and Portal Hypertension-A Prospective Study

Thromb Haemost. 2023 Dec;123(12):1140-1150. doi: 10.1055/s-0043-1771187. Epub 2023 Jul 30.

Abstract

Background: Cirrhotic patients display an increased risk for both bleeding and thrombosis. We investigated platelet activation across Child-Pugh stages (CPSs) and portal hypertension (PH) severity.

Material and methods: A total of 110 cirrhotic patients were prospectively included. CPS and hepatic venous pressure gradient (HVPG) were determined. Platelet surface expression of P-selectin and activated glycoprotein (GP) IIb/IIIa were measured by flow cytometry before/after stimulation with protease-activated receptor (PAR)-1 (thrombin receptor activating peptide, TRAP) and PAR-4 (AYPGKF) agonists, epinephrine, and lipopolysaccharide (LPS).

Results: Platelet count was similar across CPS but lower with increasing PH severity. Expression of P-selectin and activated GPIIb/IIIa in response to TRAP and AYPGKF was significantly reduced in platelets of CPS-B/C versus CPS-A patients (all p < 0.05). Platelet P-selectin expression upon epinephrine and LPS stimulation was reduced in CPS-C patients, while activated GPIIb/IIIa in response to these agonists was lower in CPS-B/C (all p < 0.05). Regarding PH severity, P-selectin and activated GPIIb/IIIa in response to AYPGKF were lower in HVPG ≥20 mmHg patients (both p < 0.001 vs. HVPG < 10 mmHg). Similarly, activated GPIIb/IIIa was lower in HVPG ≥20 mmHg patients after TRAP stimulation (p < 0.01 vs. HVPG < 10 mmHg). The lower platelet surface expression of P-selectin and activated GPIIb/IIIa upon stimulation of thrombin receptors (PAR-1/PAR-4) in CPS-B/C and HVPG ≥20 mmHg patients was paralleled by reduced antithrombin-III levels in those patients (all p < 0.05). Overall, PAR-1- and PAR-4-mediated platelet activation correlated with antithrombin-III levels (p < 0.001).

Conclusion: Platelet responsiveness decreases with increasing severity of liver cirrhosis and PH but is potentially counterbalanced by lower antithrombin-III levels.

MeSH terms

  • Anticoagulants / pharmacology
  • Antithrombins / metabolism
  • Blood Platelets / metabolism
  • Epinephrine / pharmacology
  • Humans
  • Hypertension, Portal* / diagnosis
  • Hypertension, Portal* / etiology
  • Lipopolysaccharides / pharmacology
  • Liver Cirrhosis / complications
  • Liver Cirrhosis / diagnosis
  • P-Selectin* / metabolism
  • Platelet Activation
  • Platelet Aggregation
  • Platelet Glycoprotein GPIIb-IIIa Complex / metabolism
  • Prospective Studies
  • Receptor, PAR-1 / metabolism

Substances

  • P-Selectin
  • Lipopolysaccharides
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Receptor, PAR-1
  • Anticoagulants
  • Epinephrine
  • Antithrombins